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Abstract
In 2004, France introduced a national program of organized breast cancer screening. The national
program built on pre-existing local programs in some, but not all, de´partements. Using data from multiple
waves of a nationally representative biennial survey of the French population, we estimate the effect of
organized screening on the percentage of women obtaining a mammogram. The analysis uses difference-
in-differences methods to exploit the fact that the program was targeted at women in a specific age
group: 50 to 74 years old. We find that organized screening significantly raised mammography rates
among women in the target age range. Just above the lower age threshold, the percentage of women
reporting that they had a mammogram in the past two years increased by over 10 percentage points
after the national program went into effect. Mammography rates increased even more among women in
their sixties. Estimated effects are particularly large for women with less education and lower incomes,
suggesting that France’s organized screening program has reduced socioeconomic disparities in access to
mammography.
∗For the second author, this research has been supported by a post-doctoral grant co-financed by the chair ”Sante´” at the
Fondation du risque and the project ANR 11-LABX-0019. The authors wish to thank the IRDES who provided the ESPS data
used in this paper.
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1 Introduction
Breast cancer is the most frequently diagnosed cancer and the leading cause of death from cancer among
women worldwide, accounting for one-quarter of all new cancer cases and roughly 15 percent of cancer deaths
(Torre et al., 2015). In 2015, roughly 154,400 women in the 28 countries of the European Union and 46,400
women in the U.S. died of breast cancer (Ferlay et al. (2015)). If detected early, breast cancer is highly
treatable, with very high rates of survival. Survival rates depend importantly on the stage at which breast
cancer is detected. Five-year relative survival rate for breast cancer are 99 percent for localized cancers, 85
percent for regional cancers and 26 percent for metastatic cancers (Siegel, Miller and Jemal, 2016). Early
screening increases the likelihood to detect a cancer at a more local stage, thereby improving survival.
The most common method of early detection is mammography, low dose X-ray imaging of the breasts
used to identify abnormalities. In light of evidence from clinical trials indicating that screening mammogra-
phy reduces mortality by detecting tumors at an earlier stage (Duffy and Paci, 2012), expert organizations,
including the World Health Organization’s International Agency for Research on Cancer and the American
Cancer Society, recommend regular, biennial screening mammograms starting at age 50 (Perry et al., 2008).
Nearly every European country has established a national breast cancer screening program that make mam-
mograms available free of charge for women in the recommended age range (Altobelli and Lattanzi, 2014).
Despite the central role that organized screening programs play in national cancer prevention strategies,
there is surprising little research evidence on their impact. A basic question is whether organized programs
are effective in increasing the number of women who receive mammograms. We examine this question using
data from France. The first organized programs in the country were introduced in the late 1980s and early
1990s at the level of the de´partement.1 In 2004, France established a national program that built on and
strengthened the early local programs in several ways. In particular, the target age range was expanded
slightly and the recommended frequency for mammography screening was increased to once every two years
from once every three years. By 2009, France’s organized breast cancer screening program was the largest
in the European Union in terms of the number of mammogram performed each year (Se´radour, 2010). We
evaluate the impact of both the national program and the earlier local programs using data from a nationally
representative survey of the French population spanning the period 2000 to 2010 and difference-in-differences
models that exploit variation in exposure to organized screening related to age, geography and time.
Numerous studies from multiple countries have documented significant disparities related to socioeco-
1The de´partement is the fundamental administrative and political jurisdiction in France. There are 95 de´partements in
“metropolitan France”, with an average land area of 5,666 square kilometers (3.5 times the median land area of US counties).
In terms of population, in 2015 de´partements varied in size from 76,000 to 2.6 million, with an average population of 670,000.
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nomic status in the use of a wide range of preventive health services, including cancer screening (Schueler,
Chu and Smith-Bindman, 2008; Pruitt et al., 2009; Jusot, Or and Sirven, 2012; Carrieri and Wubker, 2013;
Devaux, 2015). An important objective of population-based screening programs is to reduce such disparities
in utilization, thereby reducing disparities in cancer detection and survival. We consider whether France’s
organized screening program has reduced disparities in screening by testing for heterogeneous treatment
effects related to education and income.
Our results indicate that the early local programs increased the percentage of women who had a mam-
mogram in the past two years by roughly 6 percentage points, a 14 percent effect relative to the rate in
areas without an organized program. We estimate that the effect of the national program that went into
effect in 2004 was nearly twice as large. Although the percentage of women reporting a recent mammogram
increased for all ages within the target range, the change was greatest among women in their sixties. This
result combined with the fact that we find a weaker effect of the program on the probability of ever having
had a mammogram, suggests that the program has increased not only initiation to mammogram use, but
also the regularity with which women obtain screening. Because we find that France’s organized screening
program had a larger effect on mammography rates for women with lower socioeconomic status, gradients
with respect to education and income have declined since the national program has been in place.
2 Background and Previous Literature
2.1 Breast Cancer Screening
Breast cancer screening typically includes a clinical breast exam, a physical examination of the breast by a
physician or nurse, and a mammogram, which is an X-ray of the breast tissue that provides detailed images of
the breast from 2 angles (frontal and profile). The mammogram is performed and analyzed by a radiologist.
Screening mammograms are given to asymptomatic women to look for suspicious markers. Diagnostic
mammograms are typically given to women who have had a previous abnormal screening mammogram, have
a family history of breast cancer, or have certain symptoms, such as the presence of lumps.
The accuracy of a mammogram depends on the density of the breast tissue, which tends to decline with
age. For women over age 50, the sensitivity of the test (the probability of detecting an existing cancer) ranges
between 66 and 90 percent and specificity (the probability that the test is negative for someone without the
disease) reaches 95 percent (Smith, 2003). Thus, mammography is seen as an effective means of detecting
breast tumor for women older than 50 years old. It is considered less appropriate for younger women whose
3
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breast tissue tends to be denser.
Several studies based on randomized control trials have concluded that mammography screening leads to a
significant reduction in breast cancer mortality (Duffy and Paci, 2012). These results led to recommendations
by medical societies and public agencies that women receive regular mammograms. Reviewing evidence from
a number of micro-simulation studies, Cutler (2008) concludes that nearly half of the reduction in breast
cancer mortality in the U.S. between 1990 and 2004 can be attributed to increased screening. Recently,
however, there has been some debate about how the benefits of mammography related to reduced mortality
should be weighed against the cost associated with false positive results and overdiagnosis possibly leading
to overtreatment (Gøtzsche and Nielsen, 2009). In 2009, the U.S. Preventive Services Task Force (USPSTF)
generated some controversy when it revised its guidelines to recommend that women begin to receive regular
mammograms starting at age 50, rather than 40 as it had previously recommended. The USPSTF also revised
its recommendation regarding the frequency of screening mammograms from annual to biennial. In 2012, a
U.K. expert panel conducted a meta-analysis of the randomized trial evidence and concluded that screening
mammograms reduced the relative risk of mortality by 20 percent, while acknowledging the problem of
overdiagnosis (Marmot et al., 2012). The panel’s conclusions supported the NHS policy of organized breast
cancer screening beginning at age 50.
2.2 The Effect of Public Policies on Screening
Most countries have policies aimed at increasing the number of women who receive a regular mammogram.
In the U.S., with its fragmented system of health care financing, different strategies have been targeted at
women with different types of insurance coverage. Between the late 1980s and early 2000s, nearly every
state enacted laws requiring private health insurance plans to include screening mammograms as a covered
benefit. Recent research indicates that these benefit mandates significantly increased the percentage of
women obtaining a mammogram, with especially large effects occurring when plans were prohibited from
charging cost-sharing for the service (Bitler and Carpenter, 2016a).2 The requirement that private insurance
plans provide first-dollar coverage for screening mammograms became national policy as a result of the
Affordable Care Act. A different U.S. policy, the National Breast and Cervical Cancer Early Detection
Program (NBCCEDP), aims to increase cancer screening among uninsured low-income women. Although
it is a Federal program, the NBCCEDP was rolled out incrementally by different states throughout the
2A related literature from the U.S. examines the effect of insurance coverage on mammography use. Busch and Duchovny
(2005) and Finkelstein et al. (2012) find a positive effect of Medicaid. Several recent studies examine the effect of Massachusetts’
2006 health reform on mammography use and obtain mixed results (Kolstad and Kowalski, 2012; Keating et al., 2013; Sabik
and Bradley, 2016).
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1990s. Research exploiting that implementation pattern finds that this program also significantly increased
the percentage of women obtaining mammograms (Adams et al., 2003; Bitler and Carpenter, 2016b).
In Europe, breast cancer prevention strategies have centered on organized screening programs (Altobelli
and Lattanzi, 2014). The earliest programs, established at the local level, date to the 1980s. Finland,
Luxembourg, the UK and Sweden expanded their programs to the national level in the early 1990s. In 2003,
the European Commission formally recommended population-based screening for women between the ages
of 50 and 69. Soon thereafter, nearly every European country had established a national organized breast
cancer screening program. Although the exact details vary, these national programs share several common
elements. The modal program targets 50 to 69 year-olds.3 Every two (or a few countries three) years, women
in the target age range receive a letter inviting them to receive a free mammogram. The standard protocol
involves two images per breast and double reading of normal mammograms.
Two recent studies evaluate the effect of organized breast cancer screening programs on the utilization
of mammography, using difference-in-differences research designs. Pletscher (2017) analyzes the case of
Switzerland, where a program targeted at women between the ages of 50 and 69 was rolled out over several
years at the level of the canton. This pattern of implementation provides variation related to geography, age
and time. However, it is not clear that this variation is orthogonal to other factors affecting cancer screening.
According to Pletscher (2017), cantons that did and did not implement screening programs differed in terms
of breast cancer incidence, treatment patterns, the supply of radiologists and patient preferences. In addition,
the survey data he uses has an important limitation: the only question related to mammography use asks
if female respondents had ever had a mammogram. Thus, to the extent that organized screening affects
not only initiation to mammography but also the regularity of screening, his analysis will understate the
impact of the policy. Pletscher (2017) finds that organized screening is associated with a 4.6 percentage
point increase in the probability of ever having had a mammogram.
Carrieri and Wuebker (2016) use data from the Survey of Health, Ageing and Retirement in Europe
(SHARE) to estimate cross-sectional difference-in-differences models that compare women from 13 different
countries who were exposed to organized screening to those who were not exposed because of their age or
geographic location. Their dependent variable is an indicator for whether a woman had a mammogram in
the past two years. One limitation of their research design is that the geographic variation is measured at
the level of the NUTS-2 region, a statistical unit that does not map directly to political or administrative
3In addition to France, the Netherlands extends the target age range to 74. In Ireland and Estonia, the upper age limit is
64 and 65, respectively. In the Czech Republic, Hungary and Portugal, organized screening begins at age 45. Eligibility for the
national program of Austria and Sweden start at 40 years old.
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divisions, and therefore does not necessarily correspond to the geographic area covered by an organized
screening program.4 For example, NUTS-2 regions in Switzerland are larger than cantons, the level at where
the organized screening programs analyzed by Pletscher (2017) were implemented. Similarly, the NUTS-2
regions for France encompass multiple de´partements. Thus, it is likely that some women in the treatment
group were not actually exposed to an eligible screening program, while some women in their control group
were. And, even more than in the case of Switzerland’s cantons, differences in health care financing and
delivery among European countries raise concerns about the comparability of this study’s treatments and
controls. Their main estimates imply that organized screening programs raise the probability that a women
in the target age range has had a mammogram in the past 2 years by roughly 17 percentage points.
Numerous studies document significant socioeconomic disparities in breast cancer screening. Jusot, Or
and Sirven (2012) and Carrieri and Wubker (2013) use SHARE data to examine the socioeconomic correlates
of several types of preventive care. Both studies find that, controlling for other factors, screening rates
increase significantly with education and income. Significant disparities in mammography use have also
been documented in the U.S. (Sabatino et al., 2008; Lantz et al., 2006; McMorrow, Kenney and Goin, 2014)
and Canada (Katz and Hofer, 1994; Katz, Zemencuk and Hofer, 2000). In a comparative study of 19 OECD
countries, France ranked fourth in terms of income-related inequalities in mammography use (Devaux, 2015).
If cost is an important reason that lower income women make less use of preventive care, organized
programs that make mammograms available free of charge should reduce disparities in utilization. Similarly,
to the extent that disadvantaged women have low rates of breast cancer screening because they are not
well-informed about the benefits of mammography, the information that is provided as part of an organized
program can also reduce disparities. On the other hand, more educated, higher income women may be more
efficient users of health inputs, and therefore may be more responsive to the reduced cost and informational
intervention associated with an organized screening program. Thus, it is possible that an organized program
could amplify rather than reduce disparities in mammography use related to socioeconomic status (Goldman
and Lakdawalla, 2001).
The existing evidence on the effect of public policies on disparities in mammography utilization is limited
and mixed. Adams, Breen and Joski (2007) find that although the NBCCEDP increased breast and cervical
cancer screening in the U.S., the program did not reduce disparities in screening outcomes related to race
or ethnicity. Similarly, in his analysis of organized screening in Switzerland, Pletscher (2017) tests for
heterogeneous effects related to education and income and finds no clear pattern with respect to either. In
4NUTS stands for Nomenclature of Units for Territorial Statistics. The system was developed by Eurostat for developing,
collecting and analyzing harmonized statistics at the sub-national level.
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contrast, Carrieri and Wuebker (2016) find that organized programs have a larger effect on women with the
lowest levels of education compared to those with medium or high levels of education.
2.3 Organized Breast Cancer Screening in France
As in other European countries, organized screening in France began in the 1980s at the local level. Between
1989 and 1998, programs were launched in 27 de´partements; by 2000, there were 32 local programs. These
de´partements, which are shown as the darkest ones on the map (Figure 1), are scattered throughout the
country. This effectively random geographic dispersion of local programs and the fact that France’s health
care system is highly centralized, with uniform benefits and reimbursement policies nationwide, minimizes the
concern that the distribution of these local programs was correlated with other factors that likely influenced
the demand for or supply of mammography.
The national program was announced in 2003 and by 2004 was operational throughout France. The
current system is financed at the national level by the public health insurance funds and is overseen by the
national cancer institute, though the operation of the program is still managed at the level of the de´partement,
typically by a non-profit organization.
The protocol for the early programs involved a single image, which was read by two radiologists. The
national program is based on a new protocol, which includes two images per breast and a clinical breast exam.
Whereas the local programs sent invitation letters every three years to women between the ages of 50 and
69, under the national program women between the ages of 50 and 74 receive an invitation letter every two
years. This letter provides information one the benefits of mammography in general as well as the specific
advantages of the organized program, such as the second reading, and a list of radiologists participating
in the program. Participating radiologists must undergo a specific training, perform a minimum of 500
mammograms per year and agree to have their equipment inspected by a national agency. The goal of these
requirements is to assure a standard level of quality throughout the country. For women who accept the
invitation to the organized program, there is no charge for the mammogram. Currently, the amount that the
public insurance system pays to the radiologists for a mammogram (the “standard tariff”) is 66.42 euros.
Whether or not a woman receives a letter of invitation, she can screen “opportunistically” by obtaining
a prescription from a physician (usually a gynecologist or a general practitioner). In that case she would
face some out-of-pocket expenses. Women screening opportunistically would need to pay the standard tariff
upfront, though 70 percent of it would be reimbursed by the public health insurance system and part or all
of the remaining 30 percent would be reimbursed by private complementary insurance. Some radiologists are
7
Page 7 of 37
http://mc.manuscriptcentral.com/hec
Health Economics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
This article is protected by copyright. All rights reserved.
For Peer Review
allowed to charge more than the standard tariff. It is estimated that in 2008 the physician’s fee exceeded the
standard tariff for over 80 percent of the mammograms performed outside of the national program, with an
average extra-billing amount of 6 euros (Haute Autorite´ de Sante´, 2011). This extra-billing is not reimbursed
by the public system, though part may be reimbursed by private complementary insurance, depending on
the contract. Mammograms done outside the organized program are not necessarily read by two radiologists
and need not be combined with a clinical breast exam.
Thus, there are multiple channels by which the organized program may increase screening. First, there
may be an educational or informational effect: the letter informs women about the benefits of mammmog-
raphy and provides information about where they can obtain a mammogram. Second, the program lowers
the financial cost of screening. Third, the program may also increase utilization by affecting perceptions of
the quality of the program relative to opportunistic screening. 5
With the program’s two-year invitation cycle, women in the target age range receive an invitation letter
20-22 months after their last mammogram received through the program (if they took up the previous offer)
or their last invitation letter (if they did not). In the absence of an organized program, there would be no such
follow-up for women who had obtained a mammogram by getting a prescription from their doctor. Thus, an
organized screening program may not only affect the likelihood that a woman ever receives a mammogram,
but the regularity with which she does. A recent study by Goldzahl and Jusot (2017) is suggestive of such
an effect. They find that women who participate in the organized program are more likely than women who
obtained a mammogram outside the program to receive a second mammogram within two years.
3 Data and Methods
3.1 Data: The ESPS
Our analysis is based on data from the Enquete Sante´ et Protection Sociale (ESPS), a representative
population-based survey that has been conducted biennially since 1988 by the Institute de Recherche et
Documentation en Economie de la Sante´ (IRDES). The ESPS is administered to a sample of French house-
holds randomly drawn from public health insurance files. The survey provides information on both the
household and its members collected using both interviews (telephone or face to face) and self-administered
5A number of studies find a positive relationship between the volume of mammograms that a physician interprets and
accuracy, both in terms of sensitivity and specificity (Esserman et al., 2002; Smith-Bindman et al., 2005). Other research
finds that double reading of mammograms significantly increases cancer detection rates (Thurfjell, Lernevall and Taube, 1994;
Kopans, 2000). A qualitative study of target-age women in France found that those who had participated in the organized
program viewed the second reading as an indicator of quality (Kalecinski et al., 2015).
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questionnaires.6 We use data from the 2000, 2002, 2006, 2008 and 2010 surveys, which are the only years in
which the survey includes questions on mammography. The ESPS has a longitudinal component, whereby
half of the sample is interviewed every 4 years. Thus, some respondents were interviewed two or three times
in the five survey waves that we analyze. In our main analysis we treat the sample as a repeated cross-section.
As a sensitivity check, we also use the panel dimension to estimate models with individual fixed effects.
The timing of the surveys is well-suited for our study for several reasons. First, we have two periods of
data before and three periods after the implementation of the national screening program in 2004. Second,
all but one of the local programs that pre-dated the national program were in place by 2000.7 This facilitates
clear cross-sectional comparisons during the “pre” period and simplifies the implementation of the difference-
in-differences model to estimate the effect of the national program. Third, the fact that our first year of
“post” data is two years after the program was put in place nationally, means that nearly all women in
the target age group should have received a letter of invitation by the time they responded to the survey.
Fourth, the four-year gap between our last year of data pre-dating the national program and our first year
of “post” data means that our estimates should not be affected by short-run dynamic effects around the
implementation year. That is, our estimates should not be subject to an upward bias caused by women
delaying a mammogram they otherwise would have had in 2003 in order to benefit from the program or by
a downward bias from a “learning curve” in the initial year of the program.
There are two timing issues that could potentially cause the effect of the local program to be different
in 2000 and 2002. The first is that 8 of the 32 early local programs were started in 1998 or later. So, while
the program was in place by 2000, some eligible women may not have received their invitation letter by the
time they completed the 2000 ESPS. Second, some de´partements with local programs began transitioning to
the new protocol in 2001 and 2002. Both of these factors could result in the program having a larger impact
in 2002 than in 2000. However, we find no evidence of such a difference (as shown in table A.1). Therefore,
we pool the data from 2000 and 2002, treating it as a single “pre” period relative to the introduction of the
national program.
As in previous studies on mammography use (Sabik and Bradley, 2016; Pletscher, 2017; Carrieri and
Wuebker, 2016; Bitler and Carpenter, 2016a,b) our dependent variables are based on self-reports. In the first
two waves, the ESPS asks women whether they ever had a mammogram. Possible answers are Yes, in the
past two years ; Yes, between two and three years ago ; Yes, more than three years ago ; No, never. We
6More information on the ESPS, including questionnaires for every year, is available at
http://www.irdes.fr/recherche/enquetes/esps-enquete-sur-la-sante-et-la-protection-sociale/actualites.html.
7The exception was the Essonne, a de´partement in the greater Paris region, which established its program in January 2000.
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create a binary variable that equals who screened in the past two years. In the next three waves, the ESPS
asks women whether they have ever had a mammogram. Those answering yes are then asked to give the
date of their last mammogram. Based on these responses, we create a binary variable that equals one for
women who have had a mammogram in the past two years and zero for all others (including both women
who have never had a mammogram and women whose last mammogram was more than two years earlier).
Although the mammography question is asked of all female respondents over age 15, mammography rates
for younger women are extremely low. Therefore, we limit our main analysis to women age 35 and older.
Table 1 presents summary statistics for the full sample and for women living in de´partements with and
without a local organized screening program respectively in the pre and post-period. As we describe below,
our estimate of the effect of the local program relies on a cross-sectional comparison of women in de´partements
with and without such programs. Thus, the validity of our research design relies on the assumption that
women in de´partements without a local program are good controls for women in de´partements with a program.
The summary statistics support this assumption. In the pre-period, the two subsamples are remarkably
similar in terms of observable characteristics. The mean age is 54.4 years old in de´partements that had an
organized screening program and 55.1 years old in those that did not. In each group, just under 5 percent
of women report their health as poor, 17 percent of women report their health as fair, and 16 percent
say they are in excellent health. Between 13 and 14 percent of women in each type of de´partement are
current smokers. The percentage with private complementary health insurance—which has been shown to
be positively correlated with the utilization of outpatient care (Buchmueller et al., 2004)—is very similar
(87.1 percent in de´partements with a local program, 88.2 percent in those without) as is the distribution of
income. The one notable difference is that de´partements with local programs tend to be less rural. Despite
this, there is not a meaningful difference in the supply of services, as measured by the density of radiologists
per capita. The two groups were also quite similar in terms of the breast cancer mortality rate for the
years 1980 to 1988: in the average de´partement with a local program the rate was 17.3 deaths per 100,000
population compared to 16.5 per 100,000 in the average de´partement without a local program.8
3.2 Empirical Strategy
The quasi-experimental variation in our data allows for several different estimates of the effect of organized
breast cancer screening programs on mammography use. Let T kt be the screening rate for women in the
8We use an averaged mortality rate data from the year 1980 to 1988. This is before local programs implementation. The
reason is that we wanted to control for potential pre-local program implementation mortality differences between de´partements
in case those differences explain why some de´partements launched a local program or not. GP and radiologist density rates
were collected for the years 1998 to 2008 which is contemporaneously with surveys. The data comes from the Eco-Sante´ website
10
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target age range (50 to 74), and Ckt be the screening rate for women outside this age range, i.e., the “control”
group. The superscript k indexes two types of de´partements: those with (L) and without (N) local screening
programs. The subscript t indexes two time periods. The “pre” period (t=0) consists of the years 2000 and
2002, before the national program was established; the “post” period (t=1) consists of data from 2006 to
2010, when the national program was in place in all de´partements.
Using this notation, a simple cross-sectional estimate of the average effect of the pre-existing local pro-
grams can be obtained by comparing the screening rates for the target age group in the two types of
de´partements:
∆L = T
L
0 − TN0 . (1)
As just noted, de´partements with and without local programs are quite similar in terms of observable
characteristics. However, unobserved factors remain a potential source of bias. One can imagine the bias
going in either direction. On one hand, the “first mover” de´partements may be those with good referral
networks and radiologists with a strong orientation toward population screening. On the other hand, some
de´partements may have established organized programs in response to low rates of opportunistic screening.
If these other factors have the same effect on women within and outside the target age range, this potential
bias can be eliminated by using a cross-sectional difference-in-differences estimator:
∆∆L = (T
L
0 − TN0 )− (CL0 − CN0 ). (2)
The effect of the national program can be estimated by calculating changes in screening rates for target
group women who were not exposed to the earlier local programs, using changes for control group women
in the same de´partements to account for the effect of other factors that may have caused screening rates to
change over time. This difference-in-difference estimate can be calculated as
∆∆N = (T
N
1 − TN0 ) − (CN1 − CN0 ). (3)
Given that the national program put in place in 2004 is stronger in several respects than the pre-existing
local programs, it is of interest to test whether screening rates increased in those areas that had local
programs in place in the “pre” period. The difference-in-difference estimate
∆∆LN = (T
L
1 − TL0 )− (CL1 − CL0 ) (4)
11
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captures the combined effect of those specific elements of the national program that differ from the local
programs: the use of a 2-year rather than 3-year invitation cycle, the extension of program eligibility to age
74 rather than 69, two images per breast are taken instead of one, and the fact that women receive a clinical
exam in addition to a mammogram.
Because we have no data from years before the local programs were established, we cannot directly
estimate the full effect of the national program in these de´partements. However, we can construct an
estimate of that effect by summing the cross-sectional estimate of the effect of the local program, ∆L, with
our estimate of the effect of moving from the local program to the national program ∆∆LN . Note that
comparing this measure with our direct estimate of the effect of the national program, ∆N , provides a useful
test of the assumption that the two types of de´partements are similar, apart from when they implemented
their programs. If this assumption holds, the two estimates of the effect of the national program should be
similar.
These various estimates can be obtained from the following regression estimated on pooled data:
y = α1Local + α2Target+ α3Post+ β1Local × Target+ β2Local × Post+ β3Target× Post
+ γLocal × Target× Post+X ′θ +  (5)
In this equation Local is an indicator variable that equals one for women who live in a de´partement that
had a local screening program before 2004, Target is an indicator for women between the ages of 50 and
74, the indicator Post equals one for years after 2004, and X is a vector of control variables. The various
estimates are then:
Effect of local program: ∆∆L = β1
Effect of national program: ∆∆N = β3
Effect of transition from local to national program: ∆∆LN = β3 + γ.
3.3 Testing for Parallel Trends
Our strategy for estimating the effect of the national program relies on the assumption that the post-2004
experience of women outside the target age range represents an appropriate counterfactual for women that
were targeted by the program. A standard way to test that assumption is to examine whether outcomes for
the two groups were trending similarly before the policy was put in place. The fact that we have only two
12
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years of data from the pre-period limits our ability to analyze pre-trends. Nonetheless, it is informative to
test for differences in changes in mammography utilization between 2000 and 2002. A finding that utilization
among target age women was already increasing relative to the control group before the national program
was in place would suggest that our difference-in-differences estimates may overstate the program’s effect.
Appendix Table A.1 presents the change in mammography utilization between 2000 and 2002 for the four
categories of women defined by target group status and departement type. We see that for each category,
there was no significant change in utilization over this period. The most important comparison is between
treatments and controls in departements without a pre-existing program, since these are the observations
upon which our main estimates of the national program are based. Within these departements, the screening
rate fell by a statistically insignificant one percentage point for women in the target age range (p-value =
0.535) and increased by a statistically insignificant 0.3 percentage points for the control group (p-value =
0.881). The difference between these two estimates is also not significantly different from zero (p-value =
0.741). While estimates based on only two years of data from the ”pre” period do not provide definitive
evidence of parallel trends, these null results, along with several other findings discussed below, provide
support for our empirical strategy.
4 Results
4.1 Unadjusted Difference-in-Differences Estimates
Table 2 presents the percentage of women who had a mammogram in the past two years tabulated by
membership to the target age group of 50 to 74 years old, residence in a de´partement with a local program,
and the years before or after the implementation of the national program. These figures can be used to
calculate the various estimates just described.
Panel A reports data from the “pre” period (2000 and 2002). The first row pertains to women who are
outside the target age range and therefore not eligible for organized screening regardless of where they live. A
comparison of mammography rates for this group in the two types of de´partements provides information on
whether there are other factors affecting mammography that are correlated with the existence of a program.
The fact that the difference is not statistically significant, suggests that other confounding factors are not
a concern. As a result, when we compare mammography rates across de´partement types for women in the
target group, the simple difference, ∆L, and the difference-in-differences estimate of the program effect, ∆∆L
are essentially identical. Both imply that the local programs raised mammography rates among women in
13
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the target age range by roughly 6 percentage points, or by about 14 percent of the rate in de´partements
without an organized screening program.
Panel B presents screening rates after the national program was in effect. The comparisons across
de´partement types again suggest a strong similarity between those with and without an organized screening
program in place before 2004. As in the earlier period, there is no statistically significant difference between
the two types of de´partements among women outside of target age range. The results for women in the
target age range indicate that the implementation of the national screening program eliminated the gap in
screening rates between de´partements with and without local program. In the “post” period, 55.3 percent
of women in de´partements with an already established local program and 56.5 of women who were not
exposed to organized screening prior to 2004. The 1.2 percentage point difference between these two rates is
not statistically significant. The fact that screening rates for target group women were essentially identical
when the policy environment was the same provides additional support for interpreting the cross-sectional
difference in the pre-period as representing the effect of the local programs.
The effect of the national program can be estimated based on changes over time, which are reported in
Panel C of the table. Again, it is informative to note the differences that are not statistically significant.
In both types of de´partements there was no significant change for women outside the targeted age range,
suggesting that there were not other contemporaneous factors, such as a general increase in breast cancer
awareness or a change in clinical guidelines that might have caused screening to increase over time. In
contrast, we see significant changes for women who were eligible. For women in the target group who
were not previously exposed to a local organized screening program (column 1), the percentage with a
mammogram in the past two years increased by 13.8 percentage points, a 32 percent effect relative to the
baseline rate. Since there was no significant change for women outside the target group, the difference-in-
differences estimate of the effect of the program is essentially identical. The fact that this estimated effect
is substantially larger than the estimated effect of the local programs suggests that the ways in which the
national program strengthened the local programs had a meaningful effect. This conclusion is reinforced
by the finding that screening rates increased over time in de´partements where there was already a local
organized screening program in place. The difference-in-differences estimate of the effect of this change is
6.9 percentage points (∆∆LN= 0.063 + 0.006 = 0.069).
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4.2 Basic Regression Results
In Table 3 we report key results from linear probability regressions that generate the same set of estimates.
In the upper panel of the table we report estimated coefficients and robust standard errors (clustered by
de´partement). In the lower part of the table, we present the three difference-in-differences estimates of
interest. The model reported in column 1 includes no covariates and therefore corresponds directly to the
results in Table 2. The specifications in column 2 adds the following covariates: age, age squared, age cubed,
quintiles of household income, self-reported health status (5 categories), education (5 categories), current
or former occupation (7 categories), complementary health insurance status (3 categories) and indicator
variables for smoking, having at least one chronic health condition, living in a rural area and living in the
greater Paris region. We also control for radiologist density, GP density and the rate of mortality from breast
cancer by de´partement.
For the most part, including covariates does not have a major impact on the coefficients on the variables
of interest. One important exception is the coefficient on the indicator for being in the target group, which
is large and statistically significant in column 1 (0.177, p=0.000) and is a precisely estimated zero in the
adjusted model (p=0.999). This result provides support for our difference-in-differences approach as it
indicates that in the absence of an organized program there is not a discrete change in the probability of
having a recent mammogram associated with turning 50. In other words, our estimates of the effect of
organized screening are not capturing the effect of other factors, such as age-based clinical guidelines.
The full regression results are reported in Appendix Table A.2. In addition to the positive effect of age,
the estimated coefficients on the other control variables are consistent with results from previous studies
on the determinants of mammography use.9 Women with private complementary insurance are more likely
to have a recent mammogram than women who either have no complementary coverage or are covered by
means-tested public insurance. Current smokers are significantly less likely than non-smokers to have had
a recent mammogram, a result that may reflect preferences regarding risk and preventive medical care.
There appears to be an inverse U-shaped relationship with self-reported health. The probability of having a
mammogram in the past two years is highest for women who report their health as good and lower for those
who say it is fair, poor or excellent. The results for education and income indicate a positive gradient with
respect to socioeconomic status, an issue to which we return below.
Turning to the coefficients that represent the effect of organized screening program, we see that the
9Schueler, Chu and Smith-Bindman (2008) provide a comprehensive review of studies using data from the U.S. For a recent
analysis of the correlates of mammography use in France, see Sicsic and Franc (2014) and Goldzahl and Jusot (2017).
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adjusted differences-in-differences estimates are qualitatively similar to those from the unadjusted model.
According to the model reported in column 2, the local programs raised the percentage of target aged women
having a mammogram in the past two years by 6.6 percentage points. Modifying those programs to conform
with the new national protocols and standards raised the two-year mammography rate by an additional
4.2 percentage points. Combining these two estimates implies that the national program had the effect of
raising the mammography rate by 10.8 percentage points. This is only slightly smaller than the difference-
in-differences estimate of the effect of the national program that is identified by changes in de´partements
that did not previously have an organized program (∆∆N=.122).
Columns 3 and 4 report results a different outcome: a binary variable that equals one if a woman has ever
had a mammogram and zero otherwise. The results from the model with covariates (column 4) imply that
both the local and national programs raised the probability of every having a mammogram by between 3 and
4 percentage points. These estimates are similar to the effects that Pletscher (2017) finds for Switzerland.
The comparison between the two outcomes is informative as to the margins on which organized screening
programs operate. The fact that we find a significant effect on ever having a mammogram but larger effects
on the probability of screening in the past two years suggests that these programs have important effects on
both initiation and the regularity with which women screen.
4.3 Alternative Samples
Table 4 reports key results from models using alternative estimation samples. For ease of comparison, the
covariate-adjusted results from column 2 of Table 3 are presented in the first row. In row 2 we exploit the
limited longitudinal feature of the ESPS data by limiting the sample to respondents who appear more than
once in the data and estimating a model with individual fixed effects. The estimated program effects from
this model are comparable to our main estimates.
The next three rows illustrate the impact of changing the age criteria for the estimation sample or the
target group. Because very young and very old women may not be good controls for women in the target
age range, in row 3 we limit the sample to women between the ages of 40 and 80. In row 4, the sample
includes all women 35 and older with the exception of those who are 50 or 51 at the time of the survey.
While these women were eligible for the program, some may have not yet received an invitation letter. These
modifications also do not have a material impact on the estimates.
A particular feature of our research design is that the control group combines women who are too young
to participate in the program and women who are too old. Women under the age of 50 are a “cleaner”
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control group as they should have never received a letter inviting them to have a mammogram through the
program. In contrast, some women above the age of 74 will have participated in the program, especially
in the later years. Additionally, to the extent that their recall is not perfect, some women who received a
mammogram through the program, say, three or four years ago, may mistakenly say that they had one in
the past two years. Thus, we would expect to find stronger effects of the program if we compare the target
group only to women under age 50. Consistent with this expectation, our estimates of ∆∆L and ∆∆N are
slightly larger than the corresponding estimates for the full sample, though again the difference is small.
4.4 Accounting for Heterogeneous Effects by Age
Even though the covariate-adjusted models reported in Table 3 control flexibly for age, they restrict the
impact of organized screening to be the same for all women in the target groups. In Figure 2 and Table 5
we allow the effect of the program to vary with age, stratifying by de´partement type to account for baseline
differences in policy. The figure uses two-year age bins; in the regression we interact the the “post” variable
with indicators for five-year age categories.
The results for de´partements without a pre-existing local program (panel A of the figure and column 1 of
the table) provide the clearest evidence of the impact of the national program. When there was no organized
screening program in place, mammography rates increased with age up to age 60 and declined thereafter.
A comparison of the age profiles for the “pre” and “post” periods confirms that the implementation of the
national program had no effect on mammography rates for women under the age of 50. This is visually
apparent from the figure and can be seen by the fact that the coefficient on “post” (which represents the
change over time for 35 to 40 year olds) and the interaction of that variable and indicators for the next two
age categories (40-45, 45-49) are all insignificantly different from zero.
Mammography rates increased for all age groups within the 50 to 74 year-old target range, but the effect
was not uniform. The percentage of 50 to 54 year-olds having a recent mammogram increased by just under
9 percentage points. After the national program was in place, mammography rates increased slightly with
age up until around age 70 and then began to decline thereafter. Because mammography rates peaked at an
earlier age during the “pre” period, the implied effect of the program is larger for women in their 60s and
70s than for women in their 50s. The screening rate increased by roughly 20 percentage points for women
in their 60s and by 29 percentage points for women between 70 and 74.
There was also a statistically significant increase among women between the ages of 75 and 79, who
are just outside the target age range. Given that the dependent variable equals one for women who had a
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mammogram in the past two years, many of these women may have participated in the national screening
program just before aging out of the target group. Indeed, a supplementary analysis suggests that this is the
case. We ran separate regressions for 75–79 year-olds, allowing the effect to differ between 75–76 year-olds,
who would have been eligible for the organized program during the two year look-back period, and 77–79
year-olds, who would not have been. For the younger group, the probability of having a recent mammogram
increased by 25 percentage points, which is comparable to the effect for 70–74-year olds. The increase was
roughly half as large for 77–79 year-olds, though it was still statistically significant (p=0.005). This effect
for women just above the upper age threshold may reflect a true spillover effect. For example, after being
exposed to the organized program women may continue to have a strong demand for screening even after
they age out of the program. Alternatively, it could reflect measurement error: women may be understating
the time since their last mammogram.
In de´partements with pre-existing local programs, the largest changes were for women between the ages
of 70 and 74, who are covered by the new protocol but were outside the old protocol’s target age range. For
women in their 50s and early 60s, the change over time is much smaller and is not statistically significant.
This suggest that the expansion of the target range is a major reason for the observed difference between
the national program and the earlier local programs.
4.5 Impacts on Disparities in Screening
Having established that France’s organized breast cancer screening increased mammography use, we now turn
to the question of whether it also reduced socioeconomic disparities in screening. Table 6 presents screening
rates tabulated by education and income categories. Because we are interested in how screening changed
among affected women after the national program was implemented, we focus on women in the target age
range. To account for differences in baseline conditions, we present separate results by de´partements type.10
Looking first at de´partements without pre-existing local programs, we see that before the national pro-
gram was established there were strong gradients with respect to education and income. Women with a
middle school education were 16 percentage points more likely to report having had a mammogram in the
past 2 years than women with a primary school education or less. The rate was higher still for women with
a high school education and those with university degrees. The ratio of the rate for the highest education
10Some studies in the literature on health disparities focus on unadjusted differences among groups, while others condition
on proxies for health need and preferences as well as, in some cases, other observable characteristics. Because we are interested
in overall differences in mammography use among targeted women, we focus on unadjusted differences across education and
income groups. For a useful discussion of methodological issues concerning the measurement and analysis of health-related
disparities, see Cook, McGuire and Zaslavsky (2012).
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category to the rate for the lowest category was 1.79. The percentage of women with a recent mammogram
also increased monotonically with income, with a slightly larger ratio between the highest and lowest quin-
tiles. After the national program was in place, mammography rates increased for all education and income
categories, though the change was generally larger at the lower ends of each distribution. The changes were
18.3 and 20.9 percentage points for the lowest education and income categories, compared to just over 6
percentage points for the highest categories. As a result of this differential effect, the ratio between the top
and bottom income quintiles fell from 1.99 to 1.35.
In de´partements with pre-existing programs, the baseline gradients were less steep, which suggests that
organized screening had already reduced socioeconomic disparities there. Here, we also see greater increases
for women in lower education categories, though the differences were less pronounced than in de´partements
without pre-existing programs. In the “post” period, the ratio of the mammography rates for the top and
bottom education and income categories were similar in the two types of de´partements.
The 2006 and 2008 ESPS surveys asked not only whether a woman had a mammogram in recent years,
but those who had a mammogram were asked whether or not they received it through the organized pro-
gram. In the last column of Table 6 we present the percentage of women in each education or income
category that participated in the program. For these calculations, the sample is limited to women who had
a mammogram in the past 2 years. Because the overall utilization rate and the gradients are so similar
across de´partement types, we pool them. The results indicate a negative relationship between socioeconomic
status and participation in the organized program. Seventy percent of women with a primary education or
less who had a mammogram in the past two years received it through the program, compared to 53 percent
of women with at least a university degree. Similarly, the percentage using the program ranged from 71.5
percent in the lowest income quintile to 55.8 percent in the highest. Multiplying these percentages by the
mammography rates for the post period, gives the percentage of women in each group participating in the
program. This calculation indicates that participation was quite similar across groups and that the gradients
that remain are driven by the fact that higher SES women are more likely to go outside the program to
receive a mammogram.
The finding that the organized program had a larger impact on lower SES women is consistent with results
found by Carrieri and Wuebker (2016) and not with those of Pletscher (2017). One possible explanation is
that Pletscher (2017) tests for effects on the probability of ever having a mammogram, which we know is less
sensitive to the policy. When we replicate the analysis of Table 6 using this outcome, we see that screening
increased most for women in the lowest education and income categories, causing the ratio of screening
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rates for the highest and lowest categories to decline (results available upon request). Thus, it appears that
France’s organized screening program reduced socioeconomic disparities in mammography initiation.
5 Discussion and Conclusion
Our results provide strong evidence that French women who were eligible for a publicly funded organized
screening program were significantly more likely to have had a recent mammogram than women who were
not eligible. The fact that our estimates of the impact of the French program are similar to those found
for other European countries (Carrieri and Wuebker, 2016; Pletscher, 2017) strengthens the conclusion that
organized screening programs are successful in increasing the percentage of women obtaining a mammogram.
As with any difference-in-differences analysis, the interpretation of our results as causal effects depends
importantly on untestable assumptions about the comparability of treatment and control groups. In our
case, there are two critical comparisons, one that is cross-sectional and one related to changes over time.
Our cross-sectional estimates of the effect of the local programs that existed before 2004 relies on the
assumption that women in departements without local programs are good controls for women in departements
with such programs. Several results support this assumption. First, women in the two types of de´partements
are quite similar in observable demographic, economic and health characteristics. Second, in the years 2000
and 2002, differences in mammography use are observed only for women in the target age range. Outside this
age group, we observe no significant difference in screening rates. Third, after 2004, when a uniform policy
was in place throughout France, we see no difference in mammography utilization between de´partements that
did and did not have local programs prior to 2004. Taken together, these factors suggest that the roughly
6 percentage point difference in screening rates that we observe in that earlier period represents the causal
effect of the local programs that existed in some de´partements but not others.
Our estimate of the effect of the national program is identified by comparing changes over time for women
within and outside the target age range. Several factors support the validity of this identification strategy
as well. We see no trend in mammography rates for women in either the target or control group between
2000 and 2002. Moreover, after 2004 screening rates remained constant for the control group, suggesting the
non-importance of secular trends in breast cancer awareness, technology diffusion or other factors affecting
clinical practice. For the target group, however, there is a large and significant increase in screening after the
national program was put in place. Our preferred estimate, based on a regression model that conditions on
individual demographic, economic and health characteristics implies that the national program led to a 12
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percentage point increase in the screening rate, a 29 percent effect relative to the baseline mean. Regression
models that allow for heterogeneous effects related to age provide further evidence that the increases in
mammography utilization occurred only for women age 50 or older.
One important difference between our study and that earlier research is that we test for heterogeneous
effects related to age. Interestingly, we find the largest effects for women in their mid-60s, who are in the
middle of the target age range. This result combined with the fact that we find weaker effects on the
probability on the probability of ever having a mammogram suggest that the most important effect of the
program may not be on mammography initiation, but rather on the regularity of screening.
By eliminating financial barriers and increasing awareness of the importance of screening, organized
programs have the potential to reduce socioeconomic disparities in cancer screening. The implementation of
the national program increased mammography rates for women of all education and income levels. However,
because the increases were greater for women of lower socioeconomic status, the policy had the effect of
reducing disparities in mammography utilization.
While our results suggest that France’s organized breast cancer screening program was successful at
increasing mammography use, the ultimate goal of any such program it to reduce mortality through the timely
detection of treatable tumors. Although the benefits of mammography have long been taken as given, the
strongest empirical evidence comes from randomized clinical trials, not population-based screening programs.
The extent to which the higher rates of mammography use generated by this program led to reductions in
mortality is an empirical question that merits further research.
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Figure 1: Implementation of the local and national programs a
aThe grey areas represent the de´partements that adopted a local program before 2004.
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Figure 2: The Percentage of Women with a Mammogram in the Past 2 Years by Age
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Table 1: Summary Statistics: Full ESPS Sample, 2000-2010
Depts without a Depts with a P-value of
All local program local program the diff.
Mammogram in the past 2 yrs 0.378 0.487 0.372 0.483 0.385 0.487 0.032
Ever had a mammogram 0.531 0.499 0.526 0.499 0.537 0.499 0.006
Poor health 0.046 0.194 0.045 0.207 0.048 0.213 0.218
Fair health 0.168 0.362 0.167 0.373 0.169 0.375 0.537
Good health 0.310 0.462 0.308 0.462 0.313 0.464 0.456
Excellent health 0.160 0.382 0.163 0.369 0.157 0.364 0.161
Health unknown 0.297 0.454 0.298 0.457 0.295 0.456 0.519
Private compl. insurance 0.877 0.328 0.882 0.323 0.871 0.335 0.005
Public compl. insurance 0.054 0.226 0.051 0.219 0.058 0.235 0.003
No compl. insurance 0.008 0.091 0.009 0.097 0.010 0.097 0.979
Unknown 0.009 0.097 0.008 0.091 0.008 0.091 0.866
Has long-term condition 0.157 0.363 0.156 0.363 0.157 0.364 0.963
Smoker 0.137 0.344 0.140 0.347 0.134 0.341 0.155
Education: Primary or less 0.303 0.459 0.301 0.459 0.305 0.461 0.391
Education: Middle school 0.271 0.444 0.267 0.442 0.276 0.447 0.083
Education: High school 0.192 0.394 0.196 0.397 0.188 0.391 0.111
Education: University 0.194 0.396 0.200 0.400 0.188 0.391 0.012
Education: Other 0.040 0.195 0.037 0.189 0.043 0.202 0.018
Occupation: Farmer 0.047 0.212 0.057 0.231 0.035 0.185 0.000
Occupation: Craftsman 0.048 0.214 0.053 0.223 0.043 0.202 0.000
Occupation: Executive 0.082 0.274 0.083 0.276 0.080 0.271 0.350
Occupation: Intermediate occup. 0.176 0.381 0.181 0.385 0.170 0.376 0.024
Occupation: Employees 0.431 0.495 0.416 0.493 0.449 0.497 0.000
Occupation: Workers 0.163 0.369 0.162 0.368 0.165 0.371 0.544
Occupation: Other/Unknown 0.053 0.224 0.049 0.215 0.058 0.234 0.001
Income: 1st quintile 0.106 0.308 0.108 0.311 0.104 0.305 0.229
Income: 2nd quintile 0.123 0.329 0.125 0.331 0.121 0.327 0.313
Income: 3rd quintile 0.132 0.338 0.134 0.341 0.129 0.335 0.156
Income: 4th quintile 0.171 0.376 0.167 0.373 0.176 0.381 0.027
Income: 5th quintile 0.182 0.386 0.179 0.384 0.185 0.389 0.168
Income: Refused to answer 0.286 0.452 0.287 0.452 0.285 0.451 0.689
Rural 0.293 0.455 0.347 0.476 0.227 0.419 0.000
Paris 0.124 0.330 0.113 0.317 0.137 0.344 0.000
Age 54.779 13.600 55.095 13.805 54.395 13.337 0.000
Radiologist density 9.053 2.362 8.900 2.450 9.239 2.238 0.000
GP density 85.202 11.480 85.374 12.190 84.990 10.560 0.004
Mortality rate 1980-88 16.96 2.192 17.30 2.099 16.54 2.23 0.000
Year: 2000 0.179 0.384 0.180 0.384 0.178 0.383 0.670
Year: 2002 0.184 0.387 0.184 0.388 0.184 0.387 0.846
Year: 2006 0.204 0.403 0.207 0.405 0.202 0.401 0.299
Year: 2008 0.213 0.410 0.215 0.411 0.211 0.408 0.372
Year: 2010 0.219 0.414 0.214 0.410 0.226 0.418 0.013
Observations 29,296 16,059 13,237
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Table 2: Unadjusted Difference-in-Differences Estimates
De´partement has
a Pre-Existing Program?
A. Pre-National Program No Yes Difference
(2000 and 2002) [1] [2] [2] - [1]
Outside of Target Age Range 0.250 0.254 0.004
(0.008) (0.009) (0.012)
In Target Age Range 0.427 0.490 0.063***
(0.009) (0.011) (0.014)
B. Post-National Program
(2006 to 2010)
Outside of Target Age Range 0.235 0.248 0.012
(0.006) (0.008) (0.009)
In Target Age Range 0.565 0.553 -0.012
(0.007) (0.008) (0.010)
C. Change over Time
(B - A)
Outside of Target Age Range -0.014 -0.006
(0.010) (0.011)
In Target Age Range 0.138*** 0.063***
(0.012) (0.013)
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Table 3: Basic regression results
Mammogram Last 2 Years? Mammogram Ever?
(1) (2) (3) (4)
Local (α1) 0.004 -0.011 0.007 -0.006
(0.015) (0.012) (0.015) (0.012)
Target (α2) 0.177*** -0.002 0.186*** -0.043***
(0.013) (0.012) (0.015) (0.013)
Post (α3) -0.014 -0.026*** 0.064*** 0.035***
(0.009) (0.009) (0.010) (0.008)
Local x Target (β1) 0.059*** 0.066*** 0.031 0.037**
(0.021) (0.018) (0.022) (0.017)
Post x Local (β2) 0.009 0.012 0.012 0.017
(0.013) (0.014) (0.014) (0.013)
Post x Target (β3) 0.153*** 0.122*** 0.065*** 0.037***
(0.015) (0.014) (0.017) (0.012)
Post x Local x Target (γ) -0.084*** -0.080*** -0.061** -0.058***
(0.019) (0.017) (0.023) (0.018)
∆∆L (β1) 0.059*** 0.066*** 0.031 0.037**
(0.021) (0.018) (0.022) (0.017)
∆∆N (β3) 0.153*** 0.122*** 0.065*** 0.037***
(0.015) (0.014) (0.017) (0.012)
∆∆LN (β3 + γ) 0.069*** 0.042*** 0.004 -0.021
(0.015) (0.011) (0.016) (0.013)
N 29,296 29,296 29,296 29,296
Covariates? No Yes No Yes
Notes: The models in columns 2, 4 include the following covariates: age, age squared, age cubed,
the number of radiologists and GP per capita in the de´partement; indicators for smokers, individuals with
long-standing chronic conditions, living in a rural area, living in the greater Paris region; and
categorical variables for self-reported health, complementary health insurance coverage, education,
current or former occupation, income quintile and breast cancer mortality rate. See Appendix
Table A.2 for results corresponding to the model in column 2. ∗ ∗ ∗p < .01; ∗ ∗ p < .05; ∗p < .10
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Table 4: Regression results of robustness check specifications
∆∆L ∆∆N ∆∆LN
1. Full Sample (N = 29,296) 0.066*** 0.122*** 0.042***
(0.018) (0.014) (0.011)
2. Panel analysis (N = 17,960) 0.054*** 0.128*** 0.062***
(0.018) (0.018) (0.014)
3. Ages 40 to 80 (N = 24,305) 0.064*** 0.116*** 0.041**
(0.020) (0.014) (0.012)
4. Drop 50 & 51 Year-olds (N = 27,586) 0.067*** 0.125*** 0.049***
(0.019) (0.015) (0.012)
5. Control group 49 and younger (N=26,207) 0.079*** 0.137*** 0.039**
(0.019) (0.014) (0.011)
Notes: Covariates are included in each specification. ∗ ∗ ∗p < .01; ∗ ∗ p < .05; ∗p < .10
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Table 5: Regression results by age
De´pts w/o Local Program De´pts with Local Program
Coefficient Std. Error Coefficient Std. Error
Age (ref: 35-39)
Age 40 to 44 0.203*** (0.022) 0.200*** (0.020)
Age 45 to 49 0.308*** (0.020) 0.279*** (0.025)
Age 50 to 54 0.345*** (0.023) 0.386*** (0.020)
Age 55 to 59 0.408*** (0.023) 0.405*** (0.028)
Age 60 to 64 0.320*** (0.025) 0.424*** (0.030)
Age 65 to 69 0.272*** (0.025) 0.401*** (0.030)
Age 70 to 74 0.174*** (0.021) 0.257*** (0.041)
Age 75 to 79 -0.007 (0.019) 0.110*** (0.038)
Age 80 to 84 -0.072*** (0.019) -0.029 (0.027)
Age 85+ -0.064*** (0.021) -0.095*** (0.017)
Post -0.015 (0.015) -0.001 (0.015)
Post x 40 to 44 -0.024 (0.027) -0.029 (0.023)
Post x 45 to 49 -0.031 (0.026) 0.002 (0.031)
Post x 50 to 54 0.088*** (0.026) 0.027 (0.023)
Post x 55 to 59 0.057** (0.027) 0.042 (0.031)
Post x 60 to 64 0.192*** (0.030) 0.034 (0.040)
Post x 65 to 69 0.204*** (0.035) 0.079* (0.040)
Post x 70 to 74 0.289*** (0.035) 0.219*** (0.041)
Post x 75 to 79 0.205*** (0.031) 0.081* (0.045)
Post x 80 to 84 0.069** (0.027) 0.041 (0.035)
Post x 85+ -0.009 (0.024) 0.038 (0.026)
Constant 0.113*** (0.011) 0.107*** (0.016)
N 16,059 13,237
∗ ∗ ∗p < .01; ∗ ∗ p < .05; ∗p < .10
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Table 6: Percentage of Women Receiving a Mammogram in Past 2 Years by income and education categories
% Screened
via Organized
De´pt with no Local Program De´pts with Local Program Program
A. Differences by Education
Pre-2004 Post-2004 Change Pre-2004 Post-2004 Change Post-2004
(N = 2,562) (N = 4,806) (N = 2,072) (N = 3,994) Change (N = 3464)
Primary or less 31.8% 50.1% 18.3% *** 42.8% 50.3% 7.5%*** 70.3%
Middle School 47.8% 57.7% 9.9% *** 50.0% 58.4% 8.4%** 59.6%
High School 53.8% 63.6% 9.8 % ** 56.7% 59.3% 2.6% 61.7%
University or higher 56.8% 63.1% 6.3 % ** 63.1% 62.2% -0.9% 53.0%
University/Primary or less 1.79 1.26 1.47 1.24
B. Differences by Income
Pre-2004 Post-2004 Change Pre-2004 Post-2004 Change Post-2004
(N = 1,856) (N = 3,535) (N = 1,492) (N = 2,954) (N = 3464)
1st Quintile 33.6% 54.5% 20.9% *** 50.2% 55.2% 4.9% 71.5%
2nd Quintile 42.1% 61.4% 19.3%*** 54.5% 63.1% 8.6%** 66.0%
3rd Quintile 53.7% 66.9% 13.2% *** 60.3% 62.9% 2.6% 67.0%
4th Quintile 61.6% 67.9% 6.3% ** 66.2% 68.9% 2.8% 61.3%
5th Quintile 66.7% 73.3% 6.5%** 66.3% 67.9% 1.7% 55.8%
5th Quintile/1st Quintile 1.99 1.35 1.32 1.23
Notes: We assess if the change is statistically significant using t-tests. Screened via Organized program is only available for the years 2006 and 2008.
∗ ∗ ∗p < .01; ∗ ∗ p < .05; ∗p < .10
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A Appendix
Table A.1: Parallel trends
2000 2002 Difference
(1) (2) (1)-(2)
Local program
Outside of target age range 0.24 0.267 -0.027
(0.012) (0.012) (0.017)
In target age range 0.487 0.493 -0.005
(0.015) (0.015) (0.021)
No local program
Outside of target age range 0.251 0.248 0.003
(0.011) (0.011) (0.016)
In target age range 0.421 0.432 -0.010
(0.014) (0.013) (0.019)
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Table A.2: Basic regression results with covariates
Coefficient Std. Error
Local -0.011 (0.012)
Target -0.002 (0.012)
Post -0.027*** (0.009)
Local x Target 0.066*** (0.018)
Post x Local 0.012 (0.014)
Post x Target 0.122*** (0.014)
Post x Local x Target -0.080*** (0.017)
Health status (ref: good)
Poor -0.085*** (0.013)
Fair -0.015* (0.008)
Excellent -0.030*** (0.008)
Unknown -0.470*** (0.010)
Complementary health insurance (ref: private)
Unknown -0.044*** (0.017)
None -0.088*** (0.010)
Public -0.069*** (0.011)
Chronic disease (ref: no)
Has a chronic disease 0.016** (0.007)
Smoker -0.043*** (0.008)
Education (ref: primary or lower)
Junior High school 0.032*** (0.007)
High school 0.037*** (0.007)
University 0.040*** (0.009)
Other 0.002 (0.011)
Occupation (ref: executive)
Farmer -0.036*** (0.013)
Shopkeeper, craftmen -0.025 (0.017)
Intermediary profession 0.009 (0.011)
Employee -0.015 (0.011)
Worker -0.042*** (0.014)
Not working/other -0.078*** (0.017)
Income (ref: 1st quintile)
2nd quintile 0.023** (0.011)
3rd quintile 0.041*** (0.012)
4th quintile 0.060*** (0.010)
5th quintile 0.082*** (0.010)
Unknown 0.007 (0.009)
Rural -0.010 (0.007)
Parisian region 0.013 (0.009)
Age 0.167*** (0.009)
Age squared -0.002*** (0.000)
Aged cubed 0.000*** (0.000)
Radiologist density 0.007*** (0.001)
GP density 0.000 (0.000)
Mortality rate of breast cancer -0.001 (0.002)
Constant -3.418*** (0.171)
Observations 29,296
R-squared 0.340
Notes: ∗ ∗ ∗p < .01; ∗ ∗ p < .05; ∗p < .10
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Table A.3: Percentage of Women Receiving a Mammogram ever by income and education categories
De´pt with no Local Program De´pts with Local Program
A. Differences by Education
Pre-2004 Post-2004 Change Pre-2004 Post-2004 Change
(N = 2,562) (N = 4,806) (N = 2,072) (N = 3,994)
Primary or less 46.25% 63.90% 17.65*** 56.11% 64.16% 8.05***
Middle School 63.21% 70.98% 7.77*** 61.72% 70.66% 8.94***
High School 65.88% 75.49% 9.61*** 64.60% 72.77% 8.17**
University or higher 66.91% 74.22% 7.31** 72.48% 72.31% -0.17
University/Primary or less 1.45 1.16 1.29 1.13
B. Differences by Income
Pre-2004 Post-2004 Change Pre-2004 Post-2004 Change
(N = 1,856) (N = 3,535) (N = 1,492) (N = 2,954)
1st Quintile 52.20% 77.46% 25.26*** 65.33% 74.46% 9.13**
2nd Quintile 60.69% 77.18% 16.49*** 67.77% 79.92% 12.15***
3rd Quintile 73.03% 79.56% 6.53** 79.04% 77.72% -1.32
4th Quintile 77.42% 81.74% 4.32* 77.46% 81.45% 3.99
5th Quintile 78.69% 84.64% 5.95** 78.86% 81.39% 2.53
5th Quintile/1st Quintile 1.51 1.09 1.21 1.09
Notes: We assess if the change is statistically significant using t-tests.
∗ ∗ ∗p < .01; ∗ ∗ p < .05; ∗p < .10
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